The results of the first pilot manufacturing run, announced on
In this second pilot run, the Company looked to further optimize the manufacturing process and further reduce manufacturing time. Using Dunmore's commercial manufacturing equipment, the Company tested coating the plastic film roll in only one pass with a solution that combined all the chemicals used in the Company's REPELWRAP film formulation, so that no adjustments would be needed to the manufacturing line since there was only one coating to be applied. This second pilot run confirmed the plastic film could be coated with a combined mixture and reduce the manufacturing time compared to the first pilot run, which supports the Company's ability to further advance and optimize the manufacturing process. The Company plans to continue to refine the manufacturing process and conduct further testing including real world conditions testing.
'We are pleased with the advancements we are making as we continue to optimize the manufacturing process of the REPELWRAP film formulation and are confident that we are on track to produce a product that meets the repelling properties we aim for in a cost-efficient way.'
The Company entered into a development stage agreement with Dunmore, a
About REPELWRAP film
REPELWRAP film is the Company's first product under development and is a protective surface coating film that leverages the Company's award-winning nanotechnology. REPELWRAP film has demonstrated unique repelling properties that prevent the adhesion of pathogens, bacteria, and viruses, reducing their transmission on surfaces prone to contamination. The Company believes REPELWRAP film will have applications in healthcare settings and other industries.
About
Dunmore is a global manufacturer of engineered coated and laminated films and foils with manufacturing facilities in the
About
FendX is a
Contact:
Dr.
Tel: 1-800-344-9868
Tel: 1-833-947-5227
Email: investor@fendxtech.com
Forward-Looking Statements
This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; statements regarding conducting further refinement of the films and conducting further testing, including real world conditions testing; statements regarding the Company's intention to refine and optimize the manufacturing process of the REPELWRAP film formulation and belief the Company is on track to produce a product that meets the repelling properties it aims for in a cost-efficient way; statements regarding the Company's scale-up and commercialization initiatives; the Company's belief that REPELWRAP will have applications in healthcare settings and other industries and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-looking statements are statements that are not historical facts; they are generally, but not always, identified by the words 'expects,' 'plans,' 'anticipates,' 'believes,' 'intends,' 'estimates,' 'projects,' 'aims,' 'potential,' 'goal,' 'objective,' 'prospective,' and similar expressions, or that events or conditions 'will,' 'would,' 'may,' 'can,' 'could' or 'should' occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made and involve several risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and that actual results and future events could differ materially from those anticipated in such statements.
Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions and other risk factors set forth in the Company's public filings which are available on SEDAR+ at www.sedarplus.ca. Accordingly, the reader is urged to refer to the Company's such filings for a more complete discussion of such risk factors and their potential effects.
(C) 2024 Electronic News Publishing, source